Corticosteroid-induced skin damage improved with pimecrolimus cream 1% treatment: a 1-year study in adults with mild to moderate atopic dermatitis
Background and objectives Long-term treatment with topical corticosteroids (TCS) can lead to skin atrophy and telangiectasia at the application site. The objective of this study was to investigate if reversal of TCS-induced skin damage in patients with atopic dermatitis (AD) can be achieved by treat...
Saved in:
| Main Authors: | Diamant Thaçi, Matthias Bräutigam, Thomas Luger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of Dermatological Treatment |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2025.2493931 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Substantiation of Using Pimecrolimus 1% Cream in Proactive Therapy of Children with Atopic Dermatitis
by: Nikolay N. Murashkin, et al.
Published: (2021-11-01) -
Pimecrolimus Efficacy and Safety in Management of Children with Atopic Dermatitis
by: Nikolay N. Murashkin, et al.
Published: (2024-11-01) -
A Prospective Observational Study to Evaluate the Actual Use of 1% Pimecrolimus in Chinese Patients with Mild-to-Moderate Atopic Dermatitis Affecting Sensitive Skin Areas
by: Xie Z, et al.
Published: (2025-03-01) -
Atopic dermatitis: Tacrolimus vs. topical corticosteroid use
by: Y. Langa, et al.
Published: (2011-07-01) -
Strategies for Selecting Therapeutic Tactics for Reducing Transcutaneous Sensibilisation Risk in Infants with Atopic Dermatitis: Cohort Retrospective Prospective Study
by: Dmitri V. Fedorov, et al.
Published: (2021-03-01)